Sputnik Light

Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.

The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.

Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.

Russia's Sputnik-V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the Omicron variant of COVID-19, providing a strong defence against hospitalisation, according to a study.

The talks on the production of anti-COVID vaccine Sputnik Light in India are nearing completion, Russian Foreign Minister Sergey Lavrov said on Monday.

The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.

Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18

Sputnik Light, Russia's single-dose COVID-19 vaccine, has been found to demonstrate 70 per cent efficacy against infection with the Delta variant during the first three months after vaccination.

After the company submitted safety, immunogenicity and efficacy data, the Subject Expert Committee granted permission for conducting the trials in India.

Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.

The single-dose Sputnik Light COVID-19 vaccine is expected to launch soon in India said Russian envoy Nikolay Kudashev on Wednesday.

A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for

The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application

Coronavirus: The first dose of Russia's Sputnik V COVID-19 vaccine was administered in Hyderabad today as part of a soft launch by Dr Reddy's

Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.

The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.

Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against COVID-19, a top company official has said.

Russia's Sputnik-V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the Omicron variant of COVID-19, providing a strong defence against hospitalisation, according to a study.

The talks on the production of anti-COVID vaccine Sputnik Light in India are nearing completion, Russian Foreign Minister Sergey Lavrov said on Monday.

The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.

Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18

Sputnik Light, Russia's single-dose COVID-19 vaccine, has been found to demonstrate 70 per cent efficacy against infection with the Delta variant during the first three months after vaccination.

After the company submitted safety, immunogenicity and efficacy data, the Subject Expert Committee granted permission for conducting the trials in India.

Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.

The single-dose Sputnik Light COVID-19 vaccine is expected to launch soon in India said Russian envoy Nikolay Kudashev on Wednesday.

A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for

The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application

Coronavirus: The first dose of Russia's Sputnik V COVID-19 vaccine was administered in Hyderabad today as part of a soft launch by Dr Reddy's